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A 58-year-old man, with a history of myocardial in-
farction, hypercholesterolemia, smoking, arterial hyper-
tension, chronic obstructive pulmonary disease, paroxys-
mal atrial fibrillation, and stroke, was transferred from 
another hospital to our department to undergo high-risk 
percutaneous coronary intervention (PCI). Previously per-
formed coronary angiography revealed a multi-vessel dis-
ease with significant stenosis of the left main (LM) and 
left ascending coronary artery (LAD), as well as occlu-
sions of the right coronary artery and circumflex artery 
(Figure 1 A). Due to severely depressed left ventricular 
(LV) function (ejection fraction of 25%) and the need for 
complex PCI of the last remaining vessel, after the dis-
cussion with the heart team, he was scheduled for PCI 
with the support of a percutaneous left ventricular assist 
device (pLVAD) – so-called ‘protected PCI’ [1]. 
After the initial peripheral angiography confirming 
eligibility for using pLVAD, a  14 Fr sheath was insert-
ed into the right femoral artery. The Impella CP system 
(Abiomed Inc., Danvers MA, USA) was delivered to the 
LV and started providing a  cardiac output of 3.4 l/min. 
Subsequently, intravascular ultrasound (IVUS) guided PCI 
using the right transradial approach was started. During 
each balloon inflation, the curve of blood pressure mea-
sured in the ascending aorta was flattened (Figure 1 B), 
which meant that cardiac output was provided only by 
pLVAD. Eventually, a 3.5 × 48 mm drug-eluting stent was 
successfully implanted in the LM/LAD (Figures 1 C, D). 
The femoral artery was closed with the Perclose ProGlide 
closure system (Abbott Cardiovascular, Santa Clara, CA, 
USA). Further hospitalization was uncomplicated, and af-
ter 3 days, the patient was discharged home.
The Impella CP provides up to 4 l/min cardiac out-
put covering 70–100% of the heart contractile function 
[2]. Therefore, the arterial pressure drops during the de-
scribed procedure did not manifest themselves either as 
severe cardiac arrhythmias or cardiac arrest. The opera-
tor was able to continue the intervention, prepare highly 
calcified and complex lesions, and apply advanced percu-
taneous techniques, resulting in good stent apposition. 
As the introduction of Impella CP is relatively easy and 
safe, we assume that this device should be used more 
often in carefully selected patients, especially since the 
national healthcare system in Poland reimburses its use 
during high-risk PCIs [3]. The heart team consultation 
should help in choosing patients who will benefit from 
this technology the most.
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Figure 1. A – Baseline coronary angiography of the left coronary artery: heavy calcifications, occlusion of the 
circumflex artery and significant stenosis in the distal part of the left main artery (LM) and proximal segment 
of the left descending artery, B – blood pressure curve straightening after balloon inflation in the LM (arrow), 
C – significant stenosis of the LM imaged in intravascular coronary ultrasound (ICUS), D – ICUS confirming an 
optimal stent apposition
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